| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| General and administrative | $1.3M-2.5% | $1.3M+48.4% | $899K+11.3% | $807K |
| Research and development | $83K-77.8% | $373K-28.8% | $524K-35.2% | $809K |
| Stock-based compensation | $1.0M-60.1% | $2.6M+292.9% | $664K+156.2% | $259K |
| Total operating expenses | $2.4M-43.8% | $4.3M+106.8% | $2.1M-46.6% | $3.9M |
| Interest expense, net | $4K+4.3% | $4K+0.0% | $4K | — |
| Net loss | -$2.4M+43.8% | -$4.3M-106.7% | -$2.1M+46.6% | -$3.9M |
| Net loss per share, basic | -$0.13+45.8% | -$0.24-100.0% | -$0.12+52.0% | -$0.25 |
| Net loss per share, diluted | -$0.13+45.8% | -$0.24-100.0% | -$0.12+52.0% | -$0.25 |
| Weighted average number of common shares outstanding during the period- basic | 18.6M+3.5% | 17.9M+3.4% | 17.4M+11.3% | 15.6M |
| Weighted average number of common shares outstanding during the period- diluted | 18.6M+3.5% | 17.9M+3.4% | 17.4M+11.3% | 15.6M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.